Prevalence and Predictive Value of Intermittent Viremia With Combination HIV Therapy
Year: 2001
Type: article
Source: JAMA
Institution: University of California San Diego
Language: English
Topic: HIV Research and Treatment
Subfield: Virology
Field: Immunology and Microbiology
Domain: Life Sciences
Open Access status: closed
Funders: National Science Foundation, U.S. Department of Veterans Affairs, Bristol-Myers Squibb, Eli Lilly and Company, Pfizer, GlaxoSmithKline, Gilead Sciences, Harvard University, University of Washington, ACT Government, Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung, Universität Zürich, National Institutes of Health, Center for AIDS Research, University of Washington, University of California, San Diego, National Institute of Allergy and Infectious Diseases
OpenAlex ID: W2120752160
